Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre (TMC), Kharghar, Navi Mumbai 410210, India.
Bioinformatics Institute ASTAR, 30 Biopolis Street, #07-01 Matrix, Singapore 138671, Singapore ; Experimental Therapeutics Centre (A*STAR), 31 Biopolis Street, #03-01 Helios, Singapore 138669, Singapore.
FEBS Open Bio. 2014 Jun 6;4:571-83. doi: 10.1016/j.fob.2014.05.005. eCollection 2014.
PSMD9 (Proteasome Macropain non-ATPase subunit 9), a proteasomal assembly chaperone, harbors an uncharacterized PDZ-like domain. Here we report the identification of five novel interacting partners of PSMD9 and provide the first glimpse at the structure of the PDZ-domain, including the molecular details of the interaction. We based our strategy on two propositions: (a) proteins with conserved C-termini may share common functions and (b) PDZ domains interact with C-terminal residues of proteins. Screening of C-terminal peptides followed by interactions using full-length recombinant proteins, we discovered hnRNPA1 (an RNA binding protein), S14 (a ribosomal protein), CSH1 (a growth hormone), E12 (a transcription factor) and IL6 receptor as novel PSMD9-interacting partners. Through multiple techniques and structural insights, we clearly demonstrate for the first time that human PDZ domain interacts with the predicted Short Linear Sequence Motif (SLIM) at the C-termini of the client proteins. These interactions are also recapitulated in mammalian cells. Together, these results are suggestive of the role of PSMD9 in transcriptional regulation, mRNA processing and editing, hormone and receptor activity and protein translation. Our proof-of-principle experiments endorse a novel and quick method for the identification of putative interacting partners of similar PDZ-domain proteins from the proteome and for discovering novel functions.
PSMD9(蛋白酶体大分子非 ATP 酶亚基 9)是一种蛋白酶体组装伴侣,具有未被描述的 PDZ 样结构域。在这里,我们报道了 PSMD9 的五个新的相互作用伙伴的鉴定,并首次提供了 PDZ 结构域的结构信息,包括相互作用的分子细节。我们的策略基于两个假设:(a)具有保守 C 末端的蛋白质可能具有共同的功能,(b)PDZ 结构域与蛋白质的 C 末端残基相互作用。我们通过筛选 C 末端肽段,然后使用全长重组蛋白进行相互作用实验,发现 hnRNPA1(一种 RNA 结合蛋白)、S14(一种核糖体蛋白)、CSH1(生长激素)、E12(一种转录因子)和 IL6 受体是 PSMD9 的新的相互作用伙伴。通过多种技术和结构见解,我们首次清楚地证明了人类 PDZ 结构域与客户蛋白 C 末端的预测短线性序列基序(SLIM)相互作用。这些相互作用在哺乳动物细胞中也得到了再现。这些结果表明 PSMD9 在转录调控、mRNA 处理和编辑、激素和受体活性以及蛋白质翻译中发挥作用。我们的原理验证实验支持了一种从蛋白质组中鉴定类似 PDZ 结构域蛋白质的潜在相互作用伙伴的新的快速方法,并发现了新的功能。